Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate

Duda-Król, W.; Jórasz, I.; Dabrowska, M.; Polubiec, A.; Kusz-Rynkun, A.

Wiadomosci Lekarskie 53(7-8): 454-457

2000


ISSN/ISBN: 0043-5147
PMID: 11070769
Document Number: 7597
Lipid disorders have been treated with fibrates for many years. Rhabdomyolysis is one of the side effects of these drugs. We report a case of a septic-toxic shock due to rhabdomyolysis in a 75-year old patient, who had been treated with fenofibrate for 2 years. This case shows necessity of the standard monitoring of aminotransferase, phosphocreatine kinase and creatinine levels during treatment with fibrates.

Document emailed within 1 workday
Secure & encrypted payments

Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate